Apricot Capital

Funding rounds backed by Apricot Capital.

Export CSV
Funding disclosed in full
$192.7M
Median round
$52M
Rounds in calculation
4
4 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Vivacta Biotechnology

Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases

$50MSeries A+BiotechChina
9 participantsApricot CapitalBeijing ShunxiC&D Emerging Industry Equity InvestmentDecheng CapitalEisai Innovation Inc.HanKang CapitalLoyal Valley CapitalOrbiMedQiming Venture Partners
Vivatides Therapeutics

Develops extrahepatic RNA-targeting therapeutics

$54MSeries ABiotechChina
4 participantsApricot CapitalHighLight CapitalQiming Venture PartnersTF Capital
Excalipoint Therapeutics

Develops next-generation T-cell engager therapies for cancer and autoimmune diseases

$27.7MSeed+BiotechChina
6 participants5Y CapitalApricot CapitalCenturium CapitalEisai Innovation IncLAVMPCi
Vibrant Therapeutics

Develops intelligent, logic-gated therapeutics for solid tumors

$61MSeries ABiotechChina
6 participantsApricot CapitalBayland CapitalFirst Principle Venture LimitedHSGNorthern Light Venture CapitalPfizer Ventures